Improving Treatment Outcomes in Testicular Cancer: Strategies to Reduce Treatment Related Morbidity

BJU International

Volumn 92, Issue 6, 2003, Pages 524-526

  Huddart, R A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; ETOPOSIDE;

ANGINA PECTORIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CARDIOVASCULAR RISK; HEALTH CARE POLICY; HEALTH SURVEY; HEART INFARCTION; HUMAN; LONG TERM CARE; METASTASIS; MORBIDITY; NEUROTOXICITY; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SUDDEN DEATH; TESTIS CARCINOMA; TESTIS NONSEMINOMA CANCER; TREATMENT OUTCOME;

GERMINOMA; HUMANS; MALE; TESTICULAR NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0142028780     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04424.x     Document Type: Note

References (6)

1. Huddart R, Norman A, Shahidi M et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003; 21: 1513-23
2. Jones WD, Fossa S, Mead G et al. A randomised trial of two radiotherapy schedules in the adjuvant treatment of stage 1 seminoma (MRC TE18). In ECCO 11; 2001; the European Cancer Conference, Lisbon, 21-25. Eur J Cancer 2001; S157 (Abstract 572)
3. Jones WD, Fossa S, Mead G et al. A randomised trial of two radiotherapy schedules in the adjuvant treatment of stage 1 seminoma (MRC TE18). In ECCO 11; 2001; the European Cancer Conference, Lisbon, 21-25. Eur J Cancer 2001; S157 (Abstract 572)
4. Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 20: 4448-52
5. Lassen U, Daugaard G, Eigtved A, Hojgaard L, Damgaard K, Rorth M. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Eur J Nucl Med Mol Imaging 2003; 30: 396-402
6. Fossa SD, de Wit R, Roberts JT et al. Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 2003; 21: 1107-18